Precision Biosciences earnings were -$83.6M for the trailing 12 months ending Sep 30, 2025, with N/A growth year over year. The latest DTIL earnings report on Sep 30, 2025 announced Q3 2025 earnings of -$21.8M, down 7.4% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, DTIL reported annual earnings of $7.2M, with -111.7% growth.
Precision Biosciences Earnings Reports & History FAQ
What were Precision Biosciences's earnings last quarter?
Precision Biosciences (NASDAQ: DTIL) reported Q3 2025 earnings per share (EPS) of -$1.84, up 18.22% year over year. Total DTIL earnings for the quarter were -$21.77 million. In the same quarter last year, Precision Biosciences's earnings per share (EPS) was -$2.25.
Is Precision Biosciences profitable or losing money?
As of the last Precision Biosciences earnings report, Precision Biosciences is currently losing money. Precision Biosciences's net profit (also called net income) for the twelve months ending Sep 30, 2025 was -$83.60 million, a 1,069.52% decrease year over year.
What was DTIL's earnings growth in the past year?
As of Precision Biosciences's earnings date in Q4 2025, Precision Biosciences's earnings has grown year over year. DTIL earnings in the past year totalled -$83.60 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.